A clinical study to evaluate the efficacy and safety of Curcumin supplementation (CurQfen - The enhanced bio available formulation of curcumin) on Dementia patients having Mild to Moderate decline in Locomotor activities and impairment in Learning/Memory

Akay Flavours and Aromatics Private Limited0 个研究点目标入组 48 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Age 55-75 Years ( Both Inclusive)
•2.Male and Female Subjects
•3.Patients with a MMSE Score Less than 26 and More than 14 (Both are Inclusive)
•4.Must have a caregiver to attend the study visit.
•5.Informed consent from Subject and Legally acceptable Representative-LAR( LAR can be Spouse/Parent/Son/Daughter/Guardian/Person Having charge or any other legally acceptable Representative)

•1.Severe Memory Loss
•3.Psychiatric illness
•4.Subjects who are under the treatment with anti Inflammatory Drugs
•5.Objection from family members or any other close relatives or Legally acceptable representatives
•6.If the participation in the study cause any harm to possible benefits to the patients, including Insurance benefits.
•7.Objection from the Physician, under whom, current treatment is going on.
•8.Patients, who are in the Clinicians judgment, are like to be placed in a nursing home, within next 6 months
•9.Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.

发起方

Akay Flavours and Aromatics Private Limited